TOP STORIES
Jazz Pharmaceuticals has made a $1.5 billion offer for Celator to gain access to its drug Vyxeos, which is used to treat acute myeloid leukemia. Earlier this month, the U.S. Food and Drug Administration granted breakthrough therapy designation to Vyxeos. The deal reflects the continued dealflow in biotech. It also gives Jazz its third cancer drug. — The Wall Street Journal, Reuters
LIFE SCIENCES
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
SV Life Sciences has raised $274 million in what will be its sixth fund to invest in life sciences startups. — Boston Business Journal
Amicus Therapeutics received a thumb’s up from the European Commission for its Fabry disease therapeutic Galafold for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation. — Amicus Therapeutics
Roche got a greenlight from the European Commission for its MabThera for subcutaneous version of its treatment for chronic lymphocytic leukemia, MabThera, for people who were previously untreated and relapsed. — PharmaTimes
Can an implant wean addicts off of opioids? — CNN
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
PAYERS-PROVIDERS
Is a clinical decision support backlash brewing? — The Wall Street Journal
TECHNOLOGY
The College of Healthcare Information Executives has created the CHIME Cybersecurity Center and Program Office. The center will lead efforts to improve information sharing, develop and spread best practices, and encourage greater collaboration across the industry and with federal agencies. — CHIME
The CEO of digital health startup ProofPilot talks about the challenge of balancing expectations of investors with expectations of customers. — Venture Beat
A LITTLE BIT EXTRA
Bloomberg embraces gaming for its latest 404 error message.
Photo: Flickr